Manufacturing Classification System for oral solid dosage forms: Good in Theory and in Practice
Jan 26, 2021 12pm (Midday) UK time.
This online seminar will give an introduction to the MCS concept for the development of oral solid dosage forms (tablets and capsules). It will give case studies of its application throughout the drug development process in the areas of formulation design, process development, materials science and characterization of both API and drug product. There will be opportunity for discussion around the path forward for the MCS initiative, as well as barriers seen to future implementation.
Delegates will learn the principles of the MCS concept and how to apply it to both batch and continuous manufacture. Examples will be given of how MCS can be combined with modelling to improve drug development.
– Michael Leane, Associate Scientific Director, Bristol Myers Squibb – UK
– Tetsuya Ozeki, Chair for SIG on Drug Delivery and Manufacturing, International Pharmaceutical Federation (FIP) – Japan
– Kendal Pitt, Senior Technical Director, GlaxoSmithKline – UK
– Iris Ziegler, Director Pharmaceutical Sciences & QbD, Corden Pharma International GmbH – Germany
– Gavin Reynolds, Astra Zeneca – UK
– Neil Dawson, Senior Principal Scientist, Pfizer – UK
A link to register for the webinar can be found HERE.
Powder Flow 2021
Online Workshop and Conference: 9 -11 March 2021
From fundamentals of powder flow to state-of-the-art theories and measurements for practical applications
APS Members Discount Available
For more information and registration please click on the link
This online event will start with a 1-day workshop covering the fundamentals of powder flow followed by a 2-day technical meeting focused around the latest science underpinning powder flow and handling. It will look at progress in state-of-the-art theories and measurements in the context of practical applications and case studies
Scientific and Organising Committee
Dr Ali Hassanpour (University of Leeds)
Dr Colin Hare (University of Surrey)
Dr Tim Freeman (Freeman Technology)
Prof. Raffaella Ocone (Heriot-Watt University)
Prof. Mike Bradley (University of Greenwich)
Dr Mehrdad Pasha (UCB)
Call for Abstract
Participants are welcome to submit an abstract for the poster presentation session (best poster prize awarded).
A limited number of openings are available for oral presentations; abstracts covering work of outstanding significance are urgently invited.
Deadline for abstract submission for both oral presentation and the poster session is 31st January 2021.
World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology
11th to 14th May 2021 ONLINE
The Austria Center Vienna has informed us today that the local government has built up a SARS-CoV-2 test center in the congress halls, where we had planned to hold our 12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology on May 11-14, 2021.
Due to the current uncertain sanitary situation and limited travel options during the pandemic, the organisers decided to completely hold the PBP World Meeting and its accompanying exhibition ResearchPharm® as a virtual event on the same days.
The deadline for abstract submission is postponed to 31 January 2021.
More detailed information, e.g. on the updated registration fees, existing and new conference registrations, minor changes to the scientific programme, and technical details will follow soon.
We do hope that you may understand our decision. We promise to go to the beautiful city of Vienna with one of our future PBP World Meetings.
Further information can be found by following the link to the PBP meeting website.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.